Peter Kies Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Peter Kies is CFO of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 30,257 shares of INO, which is worth approximately $58,093. The most recent transaction as insider was on Mar 08, 2021, when has been sold 21,467 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K

7.86% 3M change

24.17% 12M change

Total Value Held $58,093

PETER KIES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2021	BUY Exercise of conversion of derivative security	-	21,467 Added 12.25%	153,749 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$133,935 $9.19 p/Share	14,574 Reduced 9.92%	132,282 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	-	27,566 Added 15.8%	146,856 Common Stock
Jan 15 2021	SELL Open market or private sale	$300,600 $10.02 p/Share	30,000 Reduced 20.1%	119,290 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$136,800 $4.56 p/Share	30,000 Added 16.73%	149,290 Common Stock
Dec 15 2020	SELL Open market or private sale	$213,800 $10.69 p/Share	20,000 Reduced 14.36%	119,290 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$45,600 $2.28 p/Share	20,000 Added 12.56%	139,290 Common Stock

Peter Kies

CFO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account